Finance

Lists
ECG:NYSE
Everus Construction Group Inc
$84.43
0.00%
(0.00) 1D
Nov 9, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECG...
Mkt. cap
4.31B
Avg. vol.
787.22K
Volume
4.81K
P/E ratio
16.98
52-wk high
$171.58
52-wk low
$70.44
EPS
$4.97
Shares outstanding
51.06M
No. of employees
9K
Mkt. cap
4.31B
Avg. vol.
787.22K
Volume
4.81K
P/E ratio
16.98
52-wk high
$171.58
52-wk low
$70.44
EPS
$4.97
Shares outstanding
51.06M
No. of employees
9K
News stories
From web sources and news partners
About Everus Construction Group Inc
CEO-
Employees9.4K
Founded2024
HeadquartersBismarck, North Dakota, United States
SectorIndustrials
IndustryConstruction
Websiteeverus.com
Analyst ratings
Based on 6 analysts giving stock ratings to ECG in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ECG in the last 3 months.
Highest
Current $84.43
$184.00 (+117.93%)
Average
$157.83 (+86.94%)
Lowest
$132.00 (+56.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Brophy
Stifel Nicolaus
Buy
Maintained
$139.00
+64.6%
11/10/2026
Unknown Analyst
Cantor Fitzgerald
Hold
Reiterated
$123.00
+45.7%
11/09/2026
Sergey Glinyanov
Freedom Capital Markets
Buy
Maintained
$170.00
+101.4%
11/05/2026
Kurt Yinger
D.A. Davidson
Buy
Maintained
$132.00
+56.3%
11/05/2026
Brent Thielman
Oppenheimer
Buy
Maintained
$170.00
+101.4%
11/05/2026
Joseph Osha
Guggenheim
Buy
Reiterated
$184.00
+117.9%
10/09/2026
Manish Somaiya
Cantor Fitzgerald
Hold
Reiterated
$152.00
+80%
08/12/2026
Ian Zaffino
Oppenheimer
Buy
Reiterated
$180.00
+113.2%
05/07/2026
Austin Wang
GLJ Research
Hold
Initiated
$141.00
+67%
04/20/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$1.79 / $1.34
+33.58%beat
Revenue / Est. (USD)
1.38B / 1.18B
+16.91%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.01B
1.04B
1.23B
1.38B
Cost of goods sold
893.97M
906.22M
1.05B
1.18B
Cost of revenue
893.97M
906.22M
1.05B
1.18B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.93M
53.04M
67.95M
75.00M
Operating expense
48.63M
53.04M
71.15M
80.70M
Total operating expenses
942.59M
959.27M
1.12B
1.26B
Operating income
68.88M
77.68M
111.77M
124.29M
Other non operating income
3.48M
799.00K
604.00K
393.00K
EBT including unusual items
73.99M
78.57M
113.29M
121.31M
EBT excluding unusual items
73.76M
78.82M
112.39M
123.40M
Income tax expense
18.71M
20.25M
29.40M
29.39M
Effective tax rate
25.29%
25.78%
25.95%
24.23%
Other operating expenses
-
-
-
-
Net income
55.28M
58.32M
83.89M
91.92M
Net profit margin
5.47%
5.62%
6.81%
6.64%
Earnings per share
1.08
1.14
1.64
1.79
Interest and investment income
1.72M
2.32M
1.33M
2.21M
Interest expense
-5.01M
-4.62M
-4.63M
-6.13M
Net interest expenses
-3.30M
-2.30M
-3.30M
-3.92M
Depreciation and amortization charges
28.70M
-
-
-
EBITDA
76.37M
85.76M
123.79M
139.29M
Gain or loss from assets sale
-829.00K
-1.97M
-1.58M
-663.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps